Kisuk Lee

Principal

St. Louis Metro Office

4 Recent Articles

July 07, 2025

U.S. Chemical & Life Science Patents Q2 Newsletter

June 26, 2025

Enablement, Anticipation, and Claim Strategy: Rethinking Biotech Patent Drafting Post-Agilent

March 19, 2024

Routine Optimization Does Not Necessarily Require a Disclosure of Ranges Under the Results-effective Variable Doctrine – Pfizer v. Sanofi, No. 19-1871 (Fed Cir 2024)

February 24, 2014

Don’t call your invention “the present invention”?